Moderna cut to sell from neutral by Rothschild & Co
Rothschild & Co downgraded Moderna to sell from neutral and raised its price target to $81.00 a share from $40.00.
Ratings actions GMT) Moderna Price Target Raised to $81.00/Share From $40.00 by Rothschild & CoRatings actions